A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)-Study protocol.
Saved in:
| Title: | A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)-Study protocol. |
|---|---|
| Authors: | Penfold S; P95 Epidemiology and Pharmacovigilance, Leuven, Belgium., Adegnika AA; Fondation pour la Recherche Scientifique (FORS), Cotonou, Bénin.; Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.; Institut für Tropenmedizin, Universität Tübingen and German Center for Infection Research, Tübingen, Germany., Asogun D; Institute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Edo State, Nigeria., Ayodeji O; Owo Federal Medical Centre, Owo, Ondo State, Nigeria., Azuogu BN; Alex Ekwueme Federal University Teaching Hospital Abakaliki, Abakaliki, Ebonyi State, Nigeria., Fischer WA 2nd; Institute of Global Health and Infectious Diseases, The University of North Carolina (UNC) at Chapel Hill, Chapel Hill, NC, United States of America., Garry RF; Tulane University School of Medicine, New Orleans, Louisiana, United States of America., Grant DS; Kenema Government Hospital (KGH), Kenema, Sierra Leone., Happi C; Redeemer's University Nigeria, Ede, Osun State, Nigeria., N'Faly M; Université Gamal Abdel Nasser de Conakry, Conakry, Guinea., Olayinka A; Nigeria Centre for Disease Control, Abuja, Nigeria., Samuels R; Kenema Government Hospital (KGH), Kenema, Sierra Leone., Sibley J; Phebe Hospital, Phebe, Liberia., Wohl DA; Institute of Global Health and Infectious Diseases, The University of North Carolina (UNC) at Chapel Hill, Chapel Hill, NC, United States of America., Accrombessi M; Fondation pour la Recherche Scientifique (FORS), Cotonou, Bénin., Adetifa I; Nigeria Centre for Disease Control, Abuja, Nigeria., Annibaldis G; Department of Virology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany., Camacho A; Epicentre, Paris, France., Dan-Nwafor C; Nigeria Centre for Disease Control, Abuja, Nigeria., Deha ARE; Fondation pour la Recherche Scientifique (FORS), Cotonou, Bénin., DeMarco J; Institute of Global Health and Infectious Diseases, The University of North Carolina (UNC) at Chapel Hill, Chapel Hill, NC, United States of America., Duraffour S; Department of Virology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany., Goba A; Kenema Government Hospital (KGH), Kenema, Sierra Leone., Grais R; Epicentre, Paris, France., Günther S; Department of Virology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany., Honvou ÉJJP; Fondation pour la Recherche Scientifique (FORS), Cotonou, Bénin., Ihekweazu C; Nigeria Centre for Disease Control, Abuja, Nigeria., Jacobsen C; Department of Virology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany., Kanneh L; Kenema Government Hospital (KGH), Kenema, Sierra Leone., Momoh M; Kenema Government Hospital (KGH), Kenema, Sierra Leone., Ndiaye A; Epicentre, Paris, France., Nsaibirni R; Epicentre, Paris, France., Okogbenin S; Institute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Edo State, Nigeria., Ochu C; Nigeria Centre for Disease Control, Abuja, Nigeria., Ogbaini E; Institute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Edo State, Nigeria., Logbo ÉPMA; Fondation pour la Recherche Scientifique (FORS), Cotonou, Bénin., Sandi JD; Kenema Government Hospital (KGH), Kenema, Sierra Leone., Schieffelin JS; Tulane University School of Medicine, New Orleans, Louisiana, United States of America., Verstraeten T; P95 Epidemiology and Pharmacovigilance, Leuven, Belgium., Vielle NJ; Department of Virology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany., Yadouleton A; Fondation pour la Recherche Scientifique (FORS), Cotonou, Bénin., Yovo EK; Fondation pour la Recherche Scientifique (FORS), Cotonou, Bénin. |
| Corporate Authors: | Enable Protocol authorship group |
| Source: | PloS one [PLoS One] 2023 Mar 30; Vol. 18 (3), pp. e0283643. Date of Electronic Publication: 2023 Mar 30 (Print Publication: 2023). |
| Publication Type: | Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1932-6203 |
|---|---|
| DOI: | 10.1371/journal.pone.0283643 |
